The recent resurgence of pertussis, or whooping cough, post-COVID-19 pandemic has sparked concern, particularly in Japan, where a delayed and dramatic outbreak in 2025 stood out for its scale and impact on older children and teens. This article delves into the reasons behind Japan's unique experience, exploring waning immunity, booster policy implications, and the challenges of protecting infants in the post-pandemic era.
The study, published in Scientific Reports, analyzed post-pandemic pertussis patterns across Japan, Australia, New Zealand, China, and the USA. It revealed a temporary suppression of cases during the pandemic, followed by a sharp resurgence post-restrictions. While most countries peaked in 2024, Japan's outbreak was delayed until 2025, with a staggering 60,826 cases by July 31, 2025, representing a tenfold increase from 2024.
This delayed surge raises questions about the effectiveness of current vaccination strategies. The study highlights a shift in the age distribution of cases, with a significant increase in incidence among teens and school-aged children in Japan. This change suggests waning immunity from childhood vaccinations and challenges booster vaccine uptake.
Geographically, Japan and New Zealand exhibited higher incidence rates in non-metropolitan areas, possibly linked to population structure, healthcare access, or vaccination coverage disparities. In contrast, Australia's outbreak was concentrated in densely populated states, while the USA showed mixed patterns.
Vaccination coverage remained high for primary childhood immunization across all countries, often exceeding 90%. However, booster vaccination strategies varied significantly. Countries with routine adolescent boosters displayed different outbreak patterns, with Japan experiencing a more pronounced surge among adolescents. This variation underscores the need for adaptive, evidence-based public health policies to address evolving infectious disease threats.
The study's findings emphasize the unintended consequences of disrupted immunity and changing public health dynamics. Japan's absence of government-funded routine pertussis boosters for adolescents and preschool children is a critical factor. This lack of boosters contributes to the delayed outbreak and the shift in age groups affected.
The implications are far-reaching. The resurgence of pertussis highlights the need for routine booster vaccines and vaccination during pregnancy as potential strategies to reduce future risk. While these measures alone may not prevent all outbreaks, they are essential components of an adaptive public health response to the evolving landscape of infectious diseases in the post-pandemic era.
In conclusion, Japan's delayed and severe pertussis outbreak in 2025 serves as a stark reminder of the complexities of managing infectious diseases in a post-pandemic world. It underscores the importance of ongoing research, adaptive vaccination strategies, and evidence-based public health policies to effectively control and prevent the resurgence of diseases like pertussis.
